SAN DIEGO, CA--(Marketwire - Apr 20, 2011) - Therapeutic Solutions International, Inc. (
"We are very excited to sign this agreement with Amalgadent," stated Tim Dixon, President of TSI. "As we begin to bring this innovative technology to markets around the world, the agreement with Amalgadent allows Australian and New Zealand dentists the ability to provide this unique chairside dental product to their patients."
"We have made our name in supplying niche dental products that supply simple solutions to previously complex problems directly to dentists," said Myer Rozen of Amalgadent. "For this reason the agreement with Therapeutic Solutions International, Inc. is a perfect fit with our philosophy. Therapeutic Solutions has products that de-mystify the areas of TMD and other sleep disorders of dental origin that previously required dentists to refer work to outside specialists. With TSI's products, patients can be offered a much more convenient and time saving service."
Mr. Rozen also commented: "This is not only cost saving for the patient but keeps the practice income within the dental practice. In these difficult economic times these cost effective solutions are of great value. By keeping the treatment within the practice many patients are able to save expensive laboratory fees, specialist fees, and the time that other appointments take. This enables people to be treated who may otherwise neglect their condition due to the inconvenience, and expense. We are excited to bring these solutions not only to dentists, but to the benefit of their patients."
About Amalgadent Dental Supplies Pty. Ltd.
First established in Melbourne, Victoria Australia in 1984, Amalgadent is often described as Australia's most innovative supplier of niche & specialty professional dental products. www.amalgadent.com.au
About Therapeutic Solutions International, Inc.
Therapeutic Solutions International, Inc. is a company whose business plan is focused on the development, production and marketing of cost effective technologies and therapeutic modalities for the treatment and prevention of common neurologic, sleep and temporomandibular disorders.
TSI has several important websites to disseminate information and market their products. Our clinical research site for the NTI is www.nti-tss.com and our e-commerce portal is located at www.ordertsi.com. Our patient education site located at www.headacheprevention.com, and our corporate website for TSI is www.therapeuticsolutionsint.com.
Safe Harbor Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to adverse economic conditions, intense competition, lack of meaningful research results, entry of new competitors and products, adverse federal, state and local government regulation, inadequate capital, termination of contracts or agreements, technological obsolescence of our products, technical problems with our research and products, price increases for supplies and components, inability to carry out research, development and commercialization plans, loss or retirement of key executives and research scientists and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Readers are advised to review our filings with the Securities and Exchange Commission that can be accessed over the Internet at the SEC's website located at http://www.sec.gov.